NBC Securities’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
NBC Securities's BIIB Position: Q2 2026 in Review
NBC Securities held its Biogen (BIIB) position steady in Q2 2026 at 49 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1876.
NBC Securities first reported a position in BIIB in Q3 2023 and has held it in 11 quarters since. The position peaked at $173K in Q2 2024. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- NBC Securities held 49 shares of Biogen worth $10.6K as of Q2 2026.
- NBC Securities left its Biogen share count unchanged in Q2 2026.
- Biogen made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #1876 holding.
- NBC Securities first reported a position in Biogen in Q3 2023 and has held it in 11 quarters since.
- NBC Securities's Biogen position peaked at $173K in Q2 2024.
- 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.